CSPC Innovation(SZ:300765) Xin Lang Cai Jing·2026-01-15 02:43Group 1 - New Nuo Wei's stock price dropped by 5.21% to 40.05 CNY per share, with a trading volume of 191 million CNY and a turnover rate of 0.33%, resulting in a total market capitalization of 56.254 billion CNY [1] - The company, Shijiazhuang Yiling Pharmaceutical Co., Ltd., was established on April 5, 2006, and listed on March 22, 2019. Its main business involves the research, production, and sales of functional foods, with revenue composition being 88.93% from functional foods and raw materials, 8.91% from biopharmaceuticals, and 2.16% from other sources [1] Group 2 - Jin Yuan Shun An Fund has a significant holding in New Nuo Wei, with its Jin Yuan Shun An Medical Health Mixed A Fund (007861) increasing its stake by 13,100 shares to a total of 48,800 shares, representing 3.75% of the fund's net value, ranking as the tenth largest holding [2] - The Jin Yuan Shun An Medical Health Mixed A Fund was established on July 29, 2021, with a latest scale of 38.3683 million CNY. Year-to-date returns are 7.33%, ranking 1797 out of 8840 in its category, while the one-year return is 14.79%, ranking 5884 out of 8094. Since inception, the fund has experienced a loss of 53.75% [2] Group 3 - The fund manager of Jin Yuan Shun An Medical Health Mixed A Fund is Chen Mingjie, who has been in position for 2 years and 82 days, with a total fund asset size of 72.6952 million CNY. The best return during his tenure is 8.68%, while the worst is -24.12% [3] - Co-manager Zhang Haidong has been in position for 144 days, managing a total fund asset size of 628 million CNY, with the best return of 5.45% and the worst return of -1.14% during his tenure [3]